IL-1β-driven SERPINE1 Upregulation is Associated with CAD-ICM-related Cardiomyocyte Remodeling.

IF 3.5 4区 医学 Q2 PHARMACOLOGY & PHARMACY
Kexin Chen, Xingyu He, Xiangming Ning, Yao Wang, Na Li, Teng Hu, Zeyuan Ma, Fengrui Yang, Yinlei Zhang, Jun Ma, Zheng Shi
{"title":"IL-1β-driven SERPINE1 Upregulation is Associated with CAD-ICM-related Cardiomyocyte Remodeling.","authors":"Kexin Chen, Xingyu He, Xiangming Ning, Yao Wang, Na Li, Teng Hu, Zeyuan Ma, Fengrui Yang, Yinlei Zhang, Jun Ma, Zheng Shi","doi":"10.2174/0113894501492572260831052957","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Coronary artery disease (CAD) may progress to ischemic cardiomyopathy (ICM) and heart failure through maladaptive cardiomyocyte remodeling and myocardial fibrosis. This study aimed to identify key molecular mediators linking inflammatory and fibrotic signaling during this pathological transition.</p><p><strong>Methods: </strong>Single-cell RNA sequencing data from human ventricular tissues, including 2 CAD, 3 ICM, and 3 healthy samples (12,818 cells; 7 cell clusters), were integrated for analysis. Cell-cell communication and pseudotime trajectory analyses were performed. Findings were further validated using a bulk transcriptomic dataset (GSE57338), a left anterior descending artery ligation mouse model, and in vitro experiments in AC16 cardiomyocytes.</p><p><strong>Results: </strong>Cardiomyocyte trajectory analysis revealed a progressive upregulation of SERPINE1 from CAD to ICM, accompanied by an expansion of SERPINE1+ cardiomyocytes enriched in inflammation- related pathways. Bulk transcriptomic data and in vivo experiments confirmed increased SERPINE1 expression in diseased myocardium. In vitro, IL-1β stimulation increased SERPINE1 expression and secretion while reducing p-SMAD2 levels. Isoproterenol (ISO) stimulation concurrently did not significantly alter SERPINE1 and SMAD2/p-SMAD2. Cardiomyocyte-specific SERPINE1 knockdown in mice partially reversed ISO-induced upregulation of fibrotic/ECM genes (Postn, Col1a1, Col3a1, Acta2), confirming its functional role in vivo.</p><p><strong>Discussion: </strong>These findings indicate that SERPINE1 is associated with inflammatory signaling during disease progression and may be regulated through mechanisms that are not fully aligned with canonical TGF-β signaling.</p><p><strong>Conclusion: </strong>SERPINE1 is dynamically regulated during CAD-to-ICM progression and may serve as a marker of disease progression. Its dissociation from canonical TGF-β signaling suggests a potential role for inflammation-related mechanisms in its regulation and in fibrotic remodeling.</p>","PeriodicalId":10805,"journal":{"name":"Current drug targets","volume":" ","pages":""},"PeriodicalIF":3.5000,"publicationDate":"2026-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current drug targets","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/0113894501492572260831052957","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Coronary artery disease (CAD) may progress to ischemic cardiomyopathy (ICM) and heart failure through maladaptive cardiomyocyte remodeling and myocardial fibrosis. This study aimed to identify key molecular mediators linking inflammatory and fibrotic signaling during this pathological transition.

Methods: Single-cell RNA sequencing data from human ventricular tissues, including 2 CAD, 3 ICM, and 3 healthy samples (12,818 cells; 7 cell clusters), were integrated for analysis. Cell-cell communication and pseudotime trajectory analyses were performed. Findings were further validated using a bulk transcriptomic dataset (GSE57338), a left anterior descending artery ligation mouse model, and in vitro experiments in AC16 cardiomyocytes.

Results: Cardiomyocyte trajectory analysis revealed a progressive upregulation of SERPINE1 from CAD to ICM, accompanied by an expansion of SERPINE1+ cardiomyocytes enriched in inflammation- related pathways. Bulk transcriptomic data and in vivo experiments confirmed increased SERPINE1 expression in diseased myocardium. In vitro, IL-1β stimulation increased SERPINE1 expression and secretion while reducing p-SMAD2 levels. Isoproterenol (ISO) stimulation concurrently did not significantly alter SERPINE1 and SMAD2/p-SMAD2. Cardiomyocyte-specific SERPINE1 knockdown in mice partially reversed ISO-induced upregulation of fibrotic/ECM genes (Postn, Col1a1, Col3a1, Acta2), confirming its functional role in vivo.

Discussion: These findings indicate that SERPINE1 is associated with inflammatory signaling during disease progression and may be regulated through mechanisms that are not fully aligned with canonical TGF-β signaling.

Conclusion: SERPINE1 is dynamically regulated during CAD-to-ICM progression and may serve as a marker of disease progression. Its dissociation from canonical TGF-β signaling suggests a potential role for inflammation-related mechanisms in its regulation and in fibrotic remodeling.

il -1β驱动的SERPINE1上调与cad - icm相关的心肌细胞重构相关
冠状动脉疾病(CAD)可通过不适应的心肌细胞重构和心肌纤维化发展为缺血性心肌病(ICM)和心力衰竭。本研究旨在确定在这种病理转变过程中连接炎症和纤维化信号的关键分子介质。方法:对2例CAD、3例ICM和3例健康样本(12818个细胞,7个细胞簇)的人体心室组织单细胞RNA测序数据进行整合分析。进行细胞间通讯和伪时间轨迹分析。通过大量转录组数据集(GSE57338)、左前降支结扎小鼠模型和AC16心肌细胞体外实验,进一步验证了研究结果。结果:心肌细胞轨迹分析显示,从CAD到ICM, SERPINE1的水平呈进行性上调,同时伴有炎症相关通路中SERPINE1+心肌细胞的扩增。大量转录组学数据和体内实验证实,SERPINE1在病变心肌中表达增加。在体外,IL-1β刺激增加SERPINE1的表达和分泌,同时降低p-SMAD2水平。异丙肾上腺素(ISO)同时刺激没有显著改变SERPINE1和SMAD2/p-SMAD2。小鼠心肌细胞特异性SERPINE1敲低部分逆转了iso诱导的纤维化/ECM基因(Postn, Col1a1, Col3a1, Acta2)的上调,证实了其在体内的功能作用。讨论:这些发现表明SERPINE1在疾病进展过程中与炎症信号相关,并可能通过与典型TGF-β信号传导不完全一致的机制进行调节。结论:SERPINE1在cad - icm进展过程中受到动态调节,可能作为疾病进展的标志。它与标准TGF-β信号的分离表明在其调节和纤维化重塑中炎症相关机制的潜在作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Current drug targets
Current drug targets 医学-药学
CiteScore
6.20
自引率
0.00%
发文量
127
审稿时长
3-8 weeks
期刊介绍: Current Drug Targets aims to cover the latest and most outstanding developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. disease specific proteins, receptors, enzymes, genes. Current Drug Targets publishes guest edited thematic issues written by leaders in the field covering a range of current topics of drug targets. The journal also accepts for publication mini- & full-length review articles and drug clinical trial studies. As the discovery, identification, characterization and validation of novel human drug targets for drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书